- Home
- CVAC vs GHLD Comparison
CVAC vs GHLD Comparison
Compare CVAC & GHLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- GHLD
- Stock Information
- Founded
- CVAC 2000
- GHLD 1960
- Country
- CVAC Germany
- GHLD United States
- Employees
- CVAC N/A
- GHLD N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- GHLD Finance: Consumer Services
- Sector
- CVAC Health Care
- GHLD Finance
- Exchange
- CVAC Nasdaq
- GHLD Nasdaq
- Market Cap
- CVAC 1.2B
- GHLD 1.2B
- IPO Year
- CVAC 2020
- GHLD 2020
- Fundamental
- Price
- CVAC $5.41
- GHLD $19.85
- Analyst Decision
- CVAC Hold
- GHLD Hold
- Analyst Count
- CVAC 3
- GHLD 6
- Target Price
- CVAC $6.83
- GHLD $17.90
- AVG Volume (30 Days)
- CVAC 974.1K
- GHLD 132.6K
- Earning Date
- CVAC 08-14-2025
- GHLD 08-07-2025
- Dividend Yield
- CVAC N/A
- GHLD 2.52%
- EPS Growth
- CVAC N/A
- GHLD 63.18
- EPS
- CVAC 0.87
- GHLD 0.71
- Revenue
- CVAC $566,039,775.00
- GHLD $1,131,796,000.00
- Revenue This Year
- CVAC N/A
- GHLD $5.64
- Revenue Next Year
- CVAC $24.04
- GHLD $26.37
- P/E Ratio
- CVAC $6.24
- GHLD $27.88
- Revenue Growth
- CVAC 787.60
- GHLD 32.57
- 52 Week Low
- CVAC $2.37
- GHLD $11.21
- 52 Week High
- CVAC $5.72
- GHLD $20.15
- Technical
- Relative Strength Index (RSI)
- CVAC 59.79
- GHLD 81.38
- Support Level
- CVAC $5.42
- GHLD $19.79
- Resistance Level
- CVAC $5.49
- GHLD $19.88
- Average True Range (ATR)
- CVAC 0.07
- GHLD 0.06
- MACD
- CVAC -0.06
- GHLD -0.21
- Stochastic Oscillator
- CVAC 36.67
- GHLD 38.89
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About GHLD Guild Holdings Company
Guild Holdings Co is a growth-oriented mortgage company. It operates in two segments; The origination segment operates its loan origination business throughout the United States. It is responsible for loan origination, acquisition, and sale activities. This segment is further divided into retail and correspondent channel, and The servicing segment provides a steady stream of cash flow to support the origination segment more importantly it allows for the Company to build long-standing client relationships that drive repeat and referral business back to the origination segment to recapture the client's next mortgage transaction. It is responsible for the servicing activities of all loans in its servicing portfolio. It generates a majority of its revenue from the Origination segment.